Table IV.
miR-21 | miR-138 | |||
---|---|---|---|---|
Variables | P-value | HR (95% CI) | P-value | HR (95% CI) |
Expression level (low vs. high) | <0.001 | 38.842 (15.203–96.215) | <0.001 | 32.562 (13.524–87.347) |
Sex (male vs. female) | 0.559 | 1.012 (0.797–1.620) | 0.845 | 1.062 (0.523–1.946) |
Age (<45 years vs. ≥45 years) | 0.114 | 1.132 (1.028–1.715) | 0.173 | 0.986 (0.946–1.042) |
TNM stage (I and II vs. III and IV) | 0.013 | 2.821 (1.346–2.857) | 0.013 | 4.182 (2.152–7.864) |
Lymph node metastasis (yes vs. no) | 0.011 | 3.053 (1.282–7.323) | 0.004 | 2.452 (1.265–4.124) |
Differentiation (low vs. high) | 0.025 | 0.921 (0.831–1.525) | 0.032 | 0.042 (0.152–0.945) |